Treatment with Upadacitinib in Active Psoriatic Arthritis: Efficacy and Safety Data of the First 192 Patients from the UPJOINT Study, a Multicentre, Observational Study in Clinical Practice

ConclusionThe data from this study confirm the findings of previous randomized controlled trials suggesting UPA is an effective treatment for active PsA without any new safety signals in patients from daily clinical practice.Clinical Trial RegistrationClinicalTrials.gov identifier, NCT04758117.
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research